2019 tables: Institutions - chemistry - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share 2017-2018*
1 Merck & Co., Inc., United States of America (USA) 22.44 22.27 37 -6.7%
2 IBM Corporation, United States of America (USA) 17.77 20.94 53 10.8%
3 Bristol-Myers Squibb (BMS), United States of America (USA) 11.35 14.52 24 20.3%
4 Pfizer Inc., United States of America (USA) 13.24 12.07 25 -14.3%
5 Thermo Fisher Scientific Inc., United States of America (USA) 4.37 9.47 37 103.6%
6 Dow Inc., United States of America (USA) 9.73 8.89 24 -14.0%
7 Johnson & Johnson, United States of America (USA) 6.09 5.95 16 -8.2%
8 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 5.33 4.78 15 -15.7%
9 Bruker Corporation, United States of America (USA) 4.90 4.69 26 -9.9%
10 AbbVie Inc., United States of America (USA) 4.21 4.58 12 2.2%
11 General Electric Company (GE), United States of America (USA) 0.79 2.56 8 205.1%
12 Abbott Laboratories, United States of America (USA) 2.50 3 N/A
13 Waters Corporation, United States of America (USA) 2.85 2.40 8 -20.8%
14 Amgen Inc., United States of America (USA) 3.55 2.38 7 -37.1%
15 Eli Lilly and Company, United States of America (USA) 5.74 2.12 11 -65.3%
16 Agilent Technologies, Inc., United States of America (USA) 2.29 2.11 5 -13.2%
17 Regeneron Pharmaceuticals, Inc., United States of America (USA) 1.03 2.00 2 82.9%
17 Novilytic, LLC, United States of America (USA) 2.00 2 N/A
18 Corning Incorporated, United States of America (USA) 0.15 1.73 3 1,017.4%
19 Leidos Holdings, Inc., United States of America (USA) 0.91 1.43 12 48.1%
20 Intel Corporation, United States of America (USA) 0.97 1.40 8 35.7%
21 New England Biolabs, Inc. (NEB), United States of America (USA) 0.65 1.34 3 92.5%
22 Xerox Corporation, United States of America (USA) 0.02 1.22 5 5,503.3%
23 Momentive, United States of America (USA) 1.20 2 N/A
24 General Motors (GM), United States of America (USA) 0.54 1.16 5 101.9%
25 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 0.11 1.00 2 746.1%
25 JEOL USA, Inc., United States of America (USA) 0.93 1.00 3 1.2%
25 Newomics, Inc., United States of America (USA) 1.00 1 N/A
25 The Chemours Company, United States of America (USA) 1.00 1 N/A
25 Alexion Pharmaceuticals, Inc., United States of America (USA) 1.00 1 N/A
25 Metabolon Inc., United States of America (USA) 1.00 1 N/A
25 Intellectual Ventures Management, LLC, United States of America (USA) 1.00 1 N/A
25 Navitor Pharmaceuticals, Inc., United States of America (USA) 1.00 1 N/A
26 Eastman Chemical Company, United States of America (USA) 1.00 3 N/A
27 HP Inc., United States of America (USA) 0.35 0.97 4 162.1%
28 D-Wave Systems, Inc., Canada 0.95 1 N/A
29 Living Proof, Inc., United States of America (USA) 0.88 1 N/A
30 InterX, Inc., United States of America (USA) 0.80 1 N/A
31 Microsoft Corporation, United States of America (USA) 1.72 0.77 7 -58.1%
32 Zymo Research Corporation, United States of America (USA) 0.75 1 N/A
33 GenNext Technologies, Inc., United States of America (USA) 0.70 1 N/A
33 Editas Medicine, Inc., United States of America (USA) 0.70 1 N/A
34 Finlay Institute - Center for Vaccines Research and Production, Cuba 0.69 1 N/A
35 Aerodyne Research, Inc. (ARI), United States of America (USA) 0.30 0.68 4 113.8%
36 Vertex Pharmaceuticals Incorporated, United States of America (USA) 0.68 2 N/A
37 Universal Display Corporation, United States of America (USA) 0.20 0.67 2 213.4%
37 BioNano Genomics, United States of America (USA) 0.67 1 N/A
38 Procter & Gamble (P&G), United States of America (USA) 0.38 0.65 3 64.2%
39 EpiCypher, Inc., United States of America (USA) 0.64 2 N/A
39 Intellectual Ventures, United States of America (USA) 0.64 1 N/A
39 Intrexon Corporation, United States of America (USA) 0.64 1 N/A
40 GenEdit Inc., United States of America (USA) 0.64 1 N/A
41 CMP Scientific, Corporation, United States of America (USA) 0.63 2 N/A
42 Ionis Pharmaceuticals, Inc., United States of America (USA) 0.60 1 N/A
42 Natron Energy, Inc., United States of America (USA) 0.60 1 N/A
43 Snapdragon Chemistry Inc., United States of America (USA) 0.83 0.58 1 -34.2%
44 IntelliSyn R&D, Canada 0.57 1 N/A
44 Halliburton Company, United States of America (USA) 0.57 1 N/A
45 Johnson Controls, Inc., United States of America (USA) 0.25 0.57 8 117.9%
46 Azimuth Corporation, United States of America (USA) 0.08 0.55 3 523.2%
47 HORIBA Instruments Incorporated, United States of America (USA) 0.54 2 N/A
48 Nion Company, United States of America (USA) 0.53 2 N/A
49 Schrödinger, LLC, United States of America (USA) 0.37 0.51 3 30.9%
50 Albemarle Corporation, United States of America (USA) 0.07 0.50 1 558.1%
50 SAFCell Inc., United States of America (USA) 0.50 1 N/A
50 New England Discovery Partners (NEDP), United States of America (USA) 0.50 1 N/A
50 Ballard Power Systems Inc., Canada 0.50 1 N/A
50 Ibis Biosciences, Inc., United States of America (USA) 0.50 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.